10-Q: Minerals Technologies Reports Q3 Loss Amid Talc Litigation
Quarterly Report
Minerals Technologies Inc. reported a net loss of $55.6 million for the nine-month period ended September 28, 2025, primarily due to a $215 million litigation reserve for talc-related claims, despite a slight increase in Q3 net sales.
Summary
- Net sales for the third quarter of 2025 increased 1% to $532.4 million, compared to $524.7 million in Q3 2024.
- Net income attributable to Minerals Technologies Inc. for Q3 2025 was $43.0 million, an 8% decrease from $46.7 million in Q3 2024.
- Diluted earnings per share for Q3 2025 were $1.37, down from $1.45 in Q3 2024.
- For the nine-month period ended September 28, 2025, net sales decreased 3% to $1,553.1 million from $1,600.4 million in 9M 2024.
- The company reported a net loss attributable to Minerals Technologies Inc. of $55.6 million for 9M 2025, a significant decline from net income of $113.1 million in 9M 2024.
- Diluted loss per share for 9M 2025 was $(1.76), compared to earnings of $3.49 in 9M 2024.
- A $215 million provision for litigation reserve and credit losses was recorded in the first quarter of 2025, primarily for estimated costs to fund a trust to resolve talc-related claims and Chapter 11 cases.
- Restructuring and other items charges totaled $11.3 million for 9M 2025, including $3.4 million for asset write-downs and $7.9 million for severance costs.
- Cash and cash equivalents stood at $319.6 million as of September 28, 2025, with over $700 million in available liquidity.
- The company repurchased $17 million in shares during Q3 2025, contributing to a total of $50.3 million (816,990 shares) under a $200 million buyback program.
Sentiment
Score: 3
Explanation: The significant net loss for the nine-month period, primarily driven by a large $215 million litigation reserve, and the ongoing uncertainties surrounding the talc-related bankruptcy proceedings, overshadow modest Q3 sales growth and segment-specific improvements. While liquidity remains strong, the substantial legal liabilities and restructuring costs present considerable headwinds, indicating a challenging financial environment.
Positives
- Net sales for the third quarter of 2025 increased 1% to $532.4 million.
- The Engineered Solutions segment saw a 4% increase in net sales in Q3 2025, reaching $255.0 million, driven by strong volume growth in Asia foundry and refractory equipment sales, and increased offshore water filtration and infrastructure drilling products.
- Income from operations for the Engineered Solutions segment grew 15% to $44.8 million in Q3 2025.
- The company maintains a strong balance sheet with over $700 million of available liquidity, including cash on hand and revolving credit facility availability.
- A share repurchase program is active, with $50.3 million in shares already repurchased under a $200 million authorization.
- Net interest expense decreased slightly in both the three-month and nine-month periods ended September 28, 2025.
- A $5.6 million net gain was realized on the final installment for the sale of refractories manufacturing assets in China during the nine-month period.
Negatives
- A net loss of $55.6 million was reported for the nine-month period ended September 28, 2025, a significant reversal from net income of $113.1 million in the prior year.
- Diluted loss per share for the nine-month period was $(1.76), compared to earnings of $3.49 in the prior year.
- A substantial $215 million provision for litigation reserve and credit losses was recorded in Q1 2025, significantly impacting profitability.
- Net income attributable to Minerals Technologies Inc. for Q3 2025 decreased 8% to $43.0 million.
- Income from operations for Q3 2025 decreased 7% to $70.9 million, and for 9M 2025, it was a loss of $14.6 million compared to income of $202.4 million in the prior year.
- Litigation expenses increased significantly to $7.5 million in Q3 2025 (from $2.6 million in Q3 2024) and $14.5 million in 9M 2025 (from $8.9 million in 9M 2024).
- Restructuring and other items charges of $11.3 million were incurred in 9M 2025, including workforce reductions and asset write-downs.
- The Consumer & Specialties segment experienced a 1% sales decrease in Q3 2025 and a 4% decrease in 9M 2025, with both Household & Personal Care and Specialty Additives product lines declining.
- Income from operations for the Consumer & Specialties segment decreased 10% in Q3 2025 and 22% in 9M 2025, attributed to unfavorable volume leverage, product mix, and weaker paper demand.
- Cash provided by operating activities decreased to $129.4 million in 9M 2025 from $166.0 million in 9M 2024.
- Production margin decreased to 25.7% in Q3 2025 (from 25.8%) and 25.3% in 9M 2025 (from 25.9%).
Risks
- Worldwide general economic, business, and industry conditions, including declining consumer and business confidence, volatile raw material prices, and inflationary pressures, may adversely affect results.
- The cyclical nature of customer businesses (metalcasting, steel, paper, construction, oil & gas) and changing regional demands can impact product demand.
- Operating in highly competitive industries, with some competitors having greater resources, could lead to pricing pressure and reduced profit margins.
- Consolidation in customer industries, particularly paper, foundry, and steel, may concentrate purchasing power and reduce sales.
- Failure to renew or extend long-term sales contracts for satellite operations could substantially affect results and lead to asset impairment.
- Servicing the company's $977.7 million debt requires significant cash, potentially reducing flexibility for capital expenditures or working capital and increasing vulnerability to adverse economic conditions.
- Debt agreements contain restrictive covenants that limit the company's ability to incur additional debt, pay dividends, sell assets, and require compliance with financial ratios, a breach of which could lead to default.
- Inability to effectively achieve and implement growth initiatives, including geographic expansion, penetration into consumer markets, and future acquisitions, could hinder future growth.
- Delays or failures in new product development could adversely affect operations.
- The company's ability to compete depends on defending its intellectual property against inappropriate disclosure, theft, and infringement.
- Increased risks of doing business abroad, including political/economic instability, changes in laws, tariffs, geopolitical threats, and currency fluctuations, could impact operations.
- Dependence on the availability of raw materials and access to ore reserves, along with increases in costs of raw materials, energy, or shipping, could adversely affect financial results.
- Risks and uncertainties related to the Chapter 11 bankruptcy cases of BMI Oldco Inc. and Barretts Ventures Texas LLC concerning talc-related liabilities, including the ultimate amount needed for the trust, potential for MTI's liability beyond the Chapter 11 Debtors, scope of Pfizer indemnity, and ongoing costs.
- Stringent environmental, health, safety, and tax regulations may lead to unanticipated costs or liabilities.
- Production facilities are subject to operating risks and capacity limitations, including hazards, unscheduled downtime, and transportation interruptions, which could adversely affect financial condition.
- Operating results for some businesses are seasonal, particularly energy services and construction activities, leading to volatile demand.
- Operations are subject to cyber-attacks and other disruptions to information systems, which could have a material adverse impact on the business.
Future Outlook
The company plans to focus on innovation and new product development for sales growth in 2025, including increasing market share in global pet litter and retinol delivery, expanding bentonite-based foundry solutions, deploying laser measurement technologies, and developing PFAS contamination products. It also aims for operational excellence and selective acquisitions. However, the imposition of tariffs and uncertainty about their scope and duration could negatively affect demand, increase input costs, or otherwise adversely affect economic conditions, which the company is monitoring and implementing mitigation plans for.
Management Comments
- Our balance sheet continues to be strong.
- We believe that these factors will allow us to meet our anticipated funding requirements.
- The Company continues to monitor the economic effects of such announcements [tariffs] and is implementing plans to mitigate their related impacts, but the effects associated with the tariffs remain uncertain.
- The Company will continue to focus on innovation and new product development and other opportunities for sales growth in 2025 from its existing businesses.
- There can be no assurance that we will achieve success in implementing any one or more of these opportunities.
- The Company's position, as stated publicly, is that the talc products sold by Oldco are safe and do not cause cancer.
- The Company supports this path forward [District Court determination on asbestos in talc].
- The Company is vigorously opposing and defending against these claims [talc-related claims].
Industry Context
The company operates in industries that are sensitive to global economic conditions and cyclical trends, such as metalcasting, steel, and paper. The paper industry, in particular, is experiencing declining production levels in North America and Europe. To mitigate these risks, the company is strategically diversifying its product portfolio into less cyclical consumer-oriented markets like pet care and personal care, and expanding into environmental solutions such as PFAS contamination remediation. Global operations are also subject to increased risks from geopolitical instability and the imposition of tariffs, which can affect demand and input costs.
Comparison to Industry Standards
- The filing does not provide specific comparable companies, projects, or global benchmarks to assess the results in the context of industry standards.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Accounting Standard Update | FASB issued ASU 2023-09, 'Improvements to Income Tax Disclosures,' requiring additional information about federal, state, and foreign income taxes. This standard is effective for periods beginning on or after December 15, 2024. | December 15, 2024 (for periods beginning on or after) | Not expected to have a material impact on consolidated financial statements, but could result in disaggregation of the company's tax footnote. |
| Accounting Standard Update | FASB issued ASU 2024-03, 'Disaggregation of Income Statement Expenses,' requiring additional disclosures about prescribed categories underlying income statement expense captions. This standard is effective for annual reporting periods beginning after December 15, 2026, and interim periods within annual reporting periods beginning after December 15, 2027. | December 15, 2026 (for annual periods beginning after) | Not expected to have a material impact on consolidated financial statements, but will result in disaggregation of the company's income statement expenses. |
Legal Proceedings
- The company and certain subsidiaries are among numerous defendants in over 800 open cases seeking damages for alleged exposure to asbestos-contaminated talc products sold by BMI Oldco Inc. (Oldco).
- Oldco and Barretts Ventures Texas LLC (BVT) filed voluntary petitions for relief under Chapter 11 of the U.S. Bankruptcy Code on October 2, 2023, to address and resolve Oldco's talc liabilities. Minerals Technologies Inc. and its other subsidiaries were not included in this filing.
- The ultimate goal of the Chapter 11 Cases is to confirm a plan of reorganization under Section 524(g) of the U.S. Bankruptcy Code to establish a trust for all current and future talc-related claims.
- A $215 million provision was recorded in Q1 2025 for estimated costs to fund this trust and related litigation, including an increase to the Debtor-in-Possession Credit Agreement.
- Litigation expenses related to Oldco's bankruptcy and talc lawsuits were $7.5 million in Q3 2025 and $14.5 million in 9M 2025.
- Pfizer Inc. filed a motion on May 22, 2024, seeking permission to file a lawsuit against the company related to a 1992 indemnification agreement, with disputes currently in mediation.
- The Bankruptcy Court denied a motion to dismiss the Chapter 11 Cases on April 29, 2025, and on May 14, 2025, recommended that the District Court determine whether any of the talc sold by Oldco contained asbestos.
- The company is unable to estimate the possible loss or range of loss beyond the accrued amount due to ongoing uncertainties in the Chapter 11 Cases and related litigation.
Related Party Transactions
- The company entered into a Debtor-in-Possession (DIP) Credit Agreement with Oldco (a subsidiary in Chapter 11) and recorded a $30 million provision for credit loss in Q2 2024, which was increased by $30 million in Q2 2025. Proceeds from this agreement are used to fund the Chapter 11 Cases.
- Historically, the majority of costs related to talc-related cases have been borne by Pfizer Inc. in connection with certain agreements from the company's 1992 initial public offering, and the company is entitled to indemnification for pre-IPO liabilities.
Stakeholder Impact
- **Shareholders**: Experienced a significant net loss and reduced EPS for the nine-month period, primarily due to legal provisions. However, the company continues its share repurchase program and declares cash dividends, providing some return and support.
- **Employees**: Affected by restructuring initiatives, including workforce reductions, which resulted in a $5.5 million charge for severance and related costs in Q1 2025.
- **Customers**: May face impacts from tariffs, which could affect demand and input costs. Conversely, they stand to benefit from the company's focus on innovation, new product development, and operational excellence aimed at improving products and sustainability.
- **Creditors**: The company is in compliance with debt covenants and maintains strong liquidity, but the substantial litigation reserve and the ongoing uncertainties of the talc-related liabilities could be a point of concern for future financial stability.
- **Suppliers**: Could be impacted by global economic conditions, tariffs, and fluctuations in demand for the company's products.
Next Steps
- Continue to focus on innovation and new product development for sales growth in 2025.
- Increase presence and market share in global pet litter products, including emerging markets.
- Deploy new products in pet care, such as lightweight litter.
- Increase sales of calcium carbonate products by further penetration into filling and coating applications in paper and packaging markets.
- Promote expertise in crystal engineering by developing crystal morphologies that help customers achieve functional benefits.
- Deploy new calcium carbonate products in paint, coating, and packaging applications.
- Continue developing products and processes for waste management and recycling opportunities.
- Continue to develop innovative applications for bleaching earth products for edible oil and renewable fuel industries.
- Develop new mineral-based solutions for personal care applications.
- Increase presence and market share globally for retinol delivery technology for personal care applications.
- Expand bentonite product solutions for animal health applications.
- Increase presence and market share in fabric care, including emerging markets.
- Increase presence and gain penetration of bentonite-based foundry solutions in emerging markets.
- Deploy value-added formulations of refractory materials that reduce costs and improve performance.
- Deploy laser measurement technologies into new applications.
- Expand refractory maintenance model to other steel makers globally.
- Continue the development and market penetration of FLUORO-SORB products for PFAS contamination.
- Pursue opportunities for the expanded use of products in environmental, building and construction, infrastructure, and oil and gas drilling and water treatment globally.
- Increase presence and market share for geosynthetic clay liners globally.
- Further operational excellence principles into all aspects of the organization, including system infrastructure and lean principles.
- Continue to explore selective acquisitions to fit competencies in minerals and core technologies.
- Monitor the economic effects of tariffs and implement plans to mitigate their related impacts.
- Ongoing discussions regarding the terms of a potential consensual plan of reorganization for talc-related claims.
- The District Court will determine whether any of the talc sold by Oldco contained sufficient quantity and form of asbestos to cause mesothelioma or other asbestos-related diseases.
Key Dates
| Date | Description |
|---|---|
| June 30, 2020 | Company issued $400 million aggregate principal amount of 5.0% Senior Notes due 2028. |
| October 2, 2023 | BMI Oldco Inc. and Barretts Ventures Texas LLC filed voluntary petitions for relief under Chapter 11 of the U.S. Bankruptcy Code (Petition Date). |
| December 2023 | FASB issued ASU 2023-09, 'Improvements to Income Tax Disclosures,' effective for periods beginning on or after December 15, 2024. |
| May 22, 2024 | Pfizer Inc. filed a motion in the Chapter 11 Cases seeking permission to file a lawsuit against the Company related to a 1992 agreement. |
| June 25, 2024 | The committee representing talc claimants filed a motion to dismiss the Chapter 11 Cases. |
| October 16, 2024 | Board of Directors authorized the repurchase of up to $200 million of the company's shares. |
| November 26, 2024 | Company entered into a Refinancing Facility Agreement and Incremental Facility Amendment, establishing new revolving credit and term loan facilities. |
| November 2024 | FASB issued ASU 2024-03, 'Disaggregation of Income Statement Expenses,' effective for annual periods beginning after December 15, 2026. |
| First quarter of 2025 | United States government announced additional tariffs; Company recorded a $215 million provision for litigation reserve and credit losses. |
| April 29, 2025 | The Bankruptcy Court denied the motion to dismiss the Chapter 11 Cases. |
| May 13, 2025 | The Committee filed a motion with the United States District Court for the Southern District of Texas seeking leave to appeal the order denying the motion to dismiss. |
| May 14, 2025 | The Bankruptcy Court entered a Report and Recommendation for the District Court to determine whether talc sold by Oldco contained asbestos. |
| Second quarter of 2025 | Company recorded a $5.8 million charge for facility consolidation; amended the Debtor-in-Possession Credit Agreement to increase the maximum principal amount by $30 million. |
| September 28, 2025 | End of the current quarterly reporting period. |
| October 14, 2025 | Number of common shares outstanding was 31,134,308. |
| October 24, 2025 | Date of the auditor's report and signing of the Form 10-Q. |
| November 26, 2029 | Maturity date for loans and commitments under the Revolving Facility. |
| November 26, 2031 | Maturity date for loans under the Term Loan Facility. |
Recommendation
holdThe company faces significant headwinds from a substantial net loss driven by a large litigation reserve for talc-related claims and ongoing legal uncertainties. While the Engineered Solutions segment shows some growth and the company maintains strong liquidity and a share buyback program, the magnitude of the legal liabilities and restructuring costs creates considerable risk. An investor should hold to monitor the resolution of the talc litigation and the effectiveness of strategic growth initiatives and cost mitigation efforts before considering further investment.
Keywords
Minerals Technologies, MTX, Quarterly Report, Financial Results, Talc Litigation, Net Loss, EPS, Specialty Minerals, Engineered Solutions, Consumer & Specialties, Revenue, Debt, Share Repurchase, Risk Factors, Environmental, Mining, Industrial Minerals, Chemicals, Corporate Governance
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.